“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Recent Posts in Business

Page 1 of 24

How NIH Uses U.S. Tax Dollars to Secure Profits for Vaccine Developers and Manufacturers

It is no secret that huge conflicts of interest exist between vaccine promoters and vaccine makers. Pediatrician and vaccine developer Paul Offit, for example, who is one of the nation’s leading promoters of mandatory use of government recommended vaccines, holds a $1.5 million research chair at Children’s Hospital in Philadelphia, funded in part by Merck.

Big Pharma Pays Universities for Most Medical Research in U.S. Today

Big Pharma Pays Universities for Most Medical Research in U.S. Today

In the past, collaboration between scientists in academia and pharmaceutical companies was relatively uncommon. However, lately there has been a growing interest in developing financial partnerships between these two sectors. The drug industry’s funding patterns for academic research has shifted from handpicked projects on investigation of…

Global Vaccines Market Worth $48 Billion by 2025

Global Vaccines Market Worth $48 Billion by 2025

The global vaccines market is projected to reach $48 billion by 2025, according to new estimates detailed in a report from Transparency Market Research. The anticipated cumulative annual growth rate (CAGR) of six percent from 2017 to 2025, however, is lower than the research firm’s previous estimate. In 2016, Transparency Market…

Page 1 of 24